Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
China-based gene therapy developer Exegenesis Bio received more than $10m in funding in August this year, raising the money from investors including Legend Star, a corporate venturing vehicle for conglomerate Legend Holdings, 36Kr reported on Monday. K2VC and Kaitai Capital also participated in the round, which will fund work on the company’s drug pipeline.
Gradient Ventures, internet technology provider Google’s artificial intelligence-focused investment vehicle, led a $10m funding round for online home insurance marketplace Young Alfred today. Existing investors Pear…
